SHC
Sotera Health Company
Price Chart
Latest Quote
$15.82
+0.36 (+2.33%)
Current Price
| Previous Close | $15.46 |
| Open | $15.56 |
| Day High | $15.85 |
| Day Low | $15.54 |
| Volume | 2,771,110 |
Stock Information
| Shares Outstanding | 285.17M |
| Total Debt | $2.27B |
| Cash Equivalents | $314.36M |
| Revenue | $1.19B |
| Net Income | $117.79M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $4.51B |
| P/E Ratio | 38.59 |
| EPS (TTM) | $0.41 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $6.47B |
| Sales | $1.19B |
| Income | $117.79M |
| Book/sh | $2.18 |
| Cash/sh | $1.10 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 2.36 |
| Current Ratio | 2.82 |
| Debt/Eq | 364.72 |
Returns & Margins
| ROA | 8.51% |
| ROE | 22.73% |
| Gross Margin | 55.26% |
| Operating Margin | 31.26% |
| Profit Margin | 9.91% |
Ownership
| Insider Ownership | 2.36% |
| Institutional Ownership | 90.31% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 14.88 |
| PEG | 1.31 |
| P/S | 3.79 |
| P/B | 7.25 |
Analyst Data
| Recommendation | buy |
| Target Price | $20.11 |
Technical Indicators
| SMA20 | $15.80 |
| SMA50 | $15.69 |
| SMA200 | $16.24 |
| RSI | 52.32 |
| ATR | 0.5456 |
| Shares Float | 191.82M |
| Short Float | 7.63% |
| Short Ratio | 4.25 |
| Volatility | 1.80 |
| Rel Volume | 1.24 |
Performance History
| Week | -3.48% |
| Month | +3.87% |
| Quarter | +16.67% |
| 6 Months | -5.27% |
| YTD | -10.57% |
| Year | +44.47% |
| 3 Years | +4.49% |
| 5 Years | -35.74% |
| 10 Years | -36.97% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $15.82 | 3,181,000 |
| 2026-06-17 | $15.46 | 3,031,900 |
| 2026-06-16 | $16.04 | 1,859,900 |
| 2026-06-15 | $16.23 | 1,782,900 |
| 2026-06-12 | $16.19 | 1,450,000 |
| 2026-06-11 | $16.39 | 3,826,900 |
| 2026-06-10 | $16.27 | 1,924,400 |
| 2026-06-09 | $16.53 | 3,661,200 |
| 2026-06-08 | $15.86 | 2,447,900 |
| 2026-06-05 | $15.62 | 2,092,600 |
| 2026-06-04 | $15.57 | 2,778,100 |
| 2026-06-03 | $15.27 | 2,481,100 |
| 2026-06-02 | $15.02 | 3,366,200 |
| 2026-06-01 | $15.54 | 1,891,500 |
| 2026-05-29 | $15.64 | 2,678,100 |
| 2026-05-28 | $15.75 | 2,314,300 |
| 2026-05-27 | $15.54 | 2,864,800 |
| 2026-05-26 | $15.96 | 3,084,000 |
| 2026-05-22 | $15.66 | 2,313,000 |
| 2026-05-21 | $15.71 | 2,073,400 |
| 2026-05-20 | $15.55 | 2,682,200 |
| 2026-05-19 | $15.23 | 2,696,500 |
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
đ° Latest News
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
StockStory âĸ 2026-06-16T14:09:04Z
Tesla upgraded, Lululemon downgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-05T13:36:13Z
1 Cash-Producing Stock Worth Your Attention and 2 That Underwhelm
StockStory âĸ 2026-06-01T12:16:51Z
3 Stocks Estimated To Be Trading Up To 44.8% Below Intrinsic Value
Simply Wall St. âĸ 2026-05-26T17:38:40Z
The Bull Case For Sotera Health (SHC) Could Change Following Term Loan Refinancing At Lower Interest Margin
Simply Wall St. âĸ 2026-05-26T15:08:05Z
A Look At Sotera Health (SHC) Valuation After Strong Q1 Beat And Upgraded Full Year Outlook
Simply Wall St. âĸ 2026-05-25T21:13:59Z
1 Small-Cap Stock to Keep an Eye On and 2 We Find Risky
StockStory âĸ 2026-05-25T11:23:51Z
Q1 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks
StockStory âĸ 2026-05-23T01:16:55Z
3 Stocks Under $50 We Find Risky
StockStory âĸ 2026-05-20T06:20:55Z
1 of Wall Streetâs Favorite Stock Worth Your Attention and 2 We Find Risky
StockStory âĸ 2026-05-18T08:20:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $412,115,000 | $396,548,000 | $378,004,000 | $364,069,000 |
| Cost Of Revenue | $518,083,000 | $498,146,000 | $472,130,000 | $446,683,000 |
| Total Revenue | $1,163,617,000 | $1,100,441,000 | $1,049,288,000 | $1,003,687,000 |
| Operating Revenue | $1,163,617,000 | $1,100,441,000 | $1,049,288,000 | $1,003,687,000 |
| Expenses | ||||
| Interest Expense | $155,722,000 | $164,691,000 | $142,878,000 | $80,144,000 |
| Total Expenses | $801,583,000 | $802,815,000 | $772,596,000 | $755,337,000 |
| Other Income Expense | $-58,806,000 | $-19,061,000 | $-27,787,000 | $-411,317,000 |
| Other Non Operating Income Expenses | $8,546,000 | $5,306,000 | $7,372,000 | $6,441,000 |
| Net Non Operating Interest Income Expense | $-155,722,000 | $-164,691,000 | $-142,878,000 | $-80,144,000 |
| Interest Expense Non Operating | $155,722,000 | $164,691,000 | $142,878,000 | $80,144,000 |
| Operating Expense | $283,500,000 | $304,669,000 | $300,466,000 | $308,654,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Net Interest Income | $-155,722,000 | $-164,691,000 | $-142,878,000 | $-80,144,000 |
| Normalized Income | $131,157,080 | $63,647,930 | $79,151,610 | $167,792,900 |
| Net Income From Continuing And Discontinued Operation | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Net Income Common Stockholders | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Net Income | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Net Income Including Noncontrolling Interests | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Net Income Continuous Operations | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Pretax Income | $147,506,000 | $113,874,000 | $106,027,000 | $-243,111,000 |
| Special Income Charges | $-66,405,000 | $-24,168,000 | $-35,000,000 | $-417,613,000 |
| Operating Income | $362,034,000 | $297,626,000 | $276,692,000 | $248,350,000 |
| Depreciation Amortization Depletion Income Statement | $30,738,000 | $62,039,000 | $63,799,000 | $62,940,000 |
| Depreciation And Amortization In Income Statement | $30,738,000 | $62,039,000 | $63,799,000 | $62,940,000 |
| Amortization Of Intangibles Income Statement | $30,738,000 | $62,039,000 | $63,799,000 | $62,940,000 |
| Gross Profit | $645,534,000 | $602,295,000 | $577,158,000 | $557,004,000 |
| Total Operating Income As Reported | - | $297,626,000 | $276,692,000 | $248,350,000 |
| Per Share | ||||
| Diluted EPS | $0.27 | $0.16 | $0.18 | $-0.83 |
| Basic EPS | $0.27 | $0.16 | $0.18 | $-0.83 |
| Other | ||||
| Tax Effect Of Unusual Items | $-14,143,920 | $-5,117,070 | $-7,383,390 | $-16,395,100 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $507,286,000 | $466,569,000 | $441,989,000 | $400,345,000 |
| Total Unusual Items | $-67,352,000 | $-24,367,000 | $-35,159,000 | $-417,758,000 |
| Total Unusual Items Excluding Goodwill | $-67,352,000 | $-24,367,000 | $-35,159,000 | $-417,758,000 |
| Reconciled Depreciation | $136,706,000 | $163,637,000 | $157,925,000 | $145,554,000 |
| EBITDA (Bullshit earnings) | $439,934,000 | $442,202,000 | $406,830,000 | $-17,413,000 |
| EBIT | $303,228,000 | $278,565,000 | $248,905,000 | $-162,967,000 |
| Diluted Average Shares | $286,421,000 | $284,906,000 | $283,222,000 | $280,096,000 |
| Basic Average Shares | $283,956,000 | $282,784,000 | $281,008,000 | $280,096,000 |
| Diluted NI Availto Com Stockholders | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Tax Provision | $69,557,000 | $69,476,000 | $54,651,000 | $-9,541,000 |
| Other Special Charges | $66,405,000 | $24,168,000 | $35,000,000 | $408,000,000 |
| Gain On Sale Of Security | $-947,000 | $-199,000 | $-159,000 | $-145,000 |
| Amortization | $30,738,000 | $62,039,000 | $63,799,000 | $62,940,000 |
| Selling General And Administration | $252,762,000 | $242,630,000 | $236,667,000 | $245,714,000 |
| Write Off | - | $0 | $0 | $9,613,000 |
| Minority Interests | - | - | $0 | $0 |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-785,424,000 | $-993,815,000 | $-1,083,774,000 | $-1,242,795,000 |
| Total Assets | $3,263,190,000 | $3,071,648,000 | $3,130,420,000 | $3,117,705,000 |
| Total Non Current Assets | $2,649,780,000 | $2,545,611,000 | $2,573,176,000 | $2,472,695,000 |
| Other Non Current Assets | $36,694,000 | $37,053,000 | $41,242,000 | $38,983,000 |
| Non Current Deferred Assets | $3,853,000 | $2,865,000 | $4,993,000 | $4,101,000 |
| Non Current Deferred Taxes Assets | $3,853,000 | $2,865,000 | $4,993,000 | $4,101,000 |
| Goodwill And Other Intangible Assets | $1,391,459,000 | $1,398,726,000 | $1,527,508,000 | $1,593,033,000 |
| Other Intangible Assets | $288,227,000 | $317,653,000 | $416,318,000 | $491,265,000 |
| Current Assets | $613,410,000 | $526,037,000 | $557,244,000 | $645,010,000 |
| Other Current Assets | $18,065,000 | $12,271,000 | $14,437,000 | $12,757,000 |
| Hedging Assets Current | $1,162,000 | $2,689,000 | $1,225,000 | $2,721,000 |
| Restricted Cash | $1,835,000 | $1,623,000 | $5,247,000 | $1,080,000 |
| Prepaid Assets | $17,086,000 | $17,244,000 | $16,093,000 | $40,376,000 |
| Inventory | $54,375,000 | $49,158,000 | $48,316,000 | $37,145,000 |
| Receivables | $176,266,000 | $165,810,000 | $175,519,000 | $155,717,000 |
| Other Receivables | $24,410,000 | $15,213,000 | $17,785,000 | $23,501,000 |
| Taxes Receivable | $12,527,000 | $10,270,000 | $10,038,000 | $13,734,000 |
| Accounts Receivable | $139,329,000 | $140,327,000 | $147,696,000 | $118,482,000 |
| Allowance For Doubtful Accounts Receivable | $-2,968,000 | $-2,532,000 | $-4,689,000 | $-1,871,000 |
| Gross Accounts Receivable | $142,297,000 | $142,859,000 | $152,385,000 | $120,353,000 |
| Cash Cash Equivalents And Short Term Investments | $344,621,000 | $277,242,000 | $296,407,000 | $395,214,000 |
| Cash And Cash Equivalents | $344,621,000 | $277,242,000 | $296,407,000 | $395,214,000 |
| Debt | ||||
| Net Debt | $1,796,076,000 | $1,945,661,000 | $1,932,064,000 | $1,549,020,000 |
| Total Debt | $2,273,653,000 | $2,350,633,000 | $2,327,056,000 | $2,032,042,000 |
| Long Term Debt And Capital Lease Obligation | $2,250,460,000 | $2,327,851,000 | $2,307,554,000 | $1,825,647,000 |
| Long Term Debt | $2,126,724,000 | $2,208,100,000 | $2,223,674,000 | $1,747,115,000 |
| Current Debt And Capital Lease Obligation | $23,193,000 | $22,782,000 | $19,502,000 | $206,395,000 |
| Current Debt | $13,973,000 | $14,803,000 | $4,797,000 | $197,119,000 |
| Other Current Borrowings | $13,973,000 | $14,803,000 | $4,797,000 | $197,119,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,657,155,000 | $2,666,737,000 | $2,686,686,000 | $2,767,467,000 |
| Total Non Current Liabilities Net Minority Interest | $2,407,571,000 | $2,475,735,000 | $2,456,032,000 | $1,975,900,000 |
| Other Non Current Liabilities | $7,360,000 | $4,418,000 | $8,879,000 | $12,831,000 |
| Non Current Deferred Liabilities | $88,132,000 | $86,284,000 | $83,216,000 | $86,926,000 |
| Non Current Deferred Taxes Liabilities | $71,075,000 | $69,500,000 | $64,454,000 | $68,024,000 |
| Current Liabilities | $249,584,000 | $191,002,000 | $230,654,000 | $791,567,000 |
| Other Current Liabilities | $1,872,000 | $4,098,000 | $414,000 | $3,508,000 |
| Current Deferred Liabilities | $17,999,000 | $15,100,000 | $13,492,000 | $12,140,000 |
| Payables And Accrued Expenses | $128,977,000 | $112,004,000 | $160,729,000 | $529,916,000 |
| Interest Payable | $20,543,000 | $25,321,000 | $26,681,000 | $23,291,000 |
| Payables | $86,943,000 | $66,580,000 | $77,596,000 | $82,573,000 |
| Total Tax Payable | $8,980,000 | $11,482,000 | $6,557,000 | $8,434,000 |
| Income Tax Payable | $5,693,000 | $7,559,000 | $4,150,000 | $5,867,000 |
| Accounts Payable | $77,963,000 | $55,098,000 | $71,039,000 | $74,139,000 |
| Equity | ||||
| Common Stock Equity | $606,035,000 | $404,911,000 | $443,734,000 | $350,238,000 |
| Total Equity Gross Minority Interest | $606,035,000 | $404,911,000 | $443,734,000 | $350,238,000 |
| Stockholders Equity | $606,035,000 | $404,911,000 | $443,734,000 | $350,238,000 |
| Gains Losses Not Affecting Retained Earnings | $-109,838,000 | $-208,251,000 | $-92,682,000 | $-106,653,000 |
| Other Equity Adjustments | $-109,838,000 | $-208,251,000 | $-92,682,000 | $-106,653,000 |
| Retained Earnings | $-532,093,000 | $-610,042,000 | $-654,440,000 | $-705,816,000 |
| Long Term Equity Investment | - | - | - | $0 |
| Investments In Other Ventures Under Equity Method | - | - | - | $0 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $1,666,000 | $2,571,000 | $3,207,000 | $3,616,000 |
| Ordinary Shares Number | $284,371,152 | $283,466,029 | $282,830,000 | $282,421,000 |
| Share Issued | $286,037,152 | $286,037,029 | $286,037,000 | $286,037,000 |
| Tangible Book Value | $-785,424,000 | $-993,815,000 | $-1,083,774,000 | $-1,242,795,000 |
| Invested Capital | $2,746,732,000 | $2,627,814,000 | $2,672,205,000 | $2,294,472,000 |
| Working Capital | $363,826,000 | $335,035,000 | $326,590,000 | $-146,557,000 |
| Capital Lease Obligations | $132,956,000 | $127,730,000 | $98,585,000 | $87,808,000 |
| Total Capitalization | $2,732,759,000 | $2,613,011,000 | $2,667,408,000 | $2,097,353,000 |
| Treasury Stock | $17,013,000 | $23,434,000 | $27,182,000 | $29,775,000 |
| Additional Paid In Capital | $1,262,119,000 | $1,243,778,000 | $1,215,178,000 | $1,189,622,000 |
| Capital Stock | $2,860,000 | $2,860,000 | $2,860,000 | $2,860,000 |
| Common Stock | $2,860,000 | $2,860,000 | $2,860,000 | $2,860,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $8,123,000 | $7,863,000 | $8,439,000 | $7,910,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $8,123,000 | $7,863,000 | $8,439,000 | $7,910,000 |
| Non Current Deferred Revenue | $17,057,000 | $16,784,000 | $18,762,000 | $18,902,000 |
| Long Term Capital Lease Obligation | $123,736,000 | $119,751,000 | $83,880,000 | $78,532,000 |
| Long Term Provisions | $53,496,000 | $49,319,000 | $47,944,000 | $42,586,000 |
| Current Deferred Revenue | $17,999,000 | $15,100,000 | $13,492,000 | $12,140,000 |
| Current Capital Lease Obligation | $9,220,000 | $7,979,000 | $14,705,000 | $9,276,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $43,543,000 | $37,018,000 | $35,037,000 | $32,936,000 |
| Current Provisions | $34,000,000 | - | $1,480,000 | $6,672,000 |
| Current Accrued Expenses | $42,034,000 | $45,424,000 | $83,133,000 | $447,343,000 |
| Defined Pension Benefit | $53,817,000 | $42,524,000 | $28,482,000 | $35,570,000 |
| Goodwill | $1,103,232,000 | $1,081,073,000 | $1,111,190,000 | $1,101,768,000 |
| Net PPE | $1,163,957,000 | $1,064,443,000 | $970,951,000 | $801,008,000 |
| Accumulated Depreciation | $-671,859,000 | $-562,413,000 | $-504,777,000 | $-438,896,000 |
| Gross PPE | $1,835,816,000 | $1,626,856,000 | $1,475,728,000 | $1,239,904,000 |
| Leases | $128,313,000 | $98,028,000 | $82,582,000 | $67,386,000 |
| Construction In Progress | $259,919,000 | $250,418,000 | $247,019,000 | $193,639,000 |
| Other Properties | $41,318,000 | $34,919,000 | $30,627,000 | $30,736,000 |
| Machinery Furniture Equipment | $935,361,000 | $825,453,000 | $770,191,000 | $630,213,000 |
| Land And Improvements | $470,905,000 | $418,038,000 | $345,309,000 | $317,930,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-252,000 | $-218,000 | $-236,000 | $-117,000 |
| Finished Goods | $6,622,000 | $6,039,000 | $4,670,000 | $276,000 |
| Work In Process | $2,436,000 | $929,000 | $471,000 | $584,000 |
| Raw Materials | $45,569,000 | $42,408,000 | $43,411,000 | $36,402,000 |
| Minority Interest | - | - | $0 | $0 |
| Investments And Advances | - | - | - | $0 |
| Investmentsin Associatesat Cost | - | - | - | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $149,177,000 | $45,094,000 | $-362,707,000 | $95,583,000 |
| Operating Activities | ||||
| Operating Cash Flow | $287,195,000 | $224,164,000 | $-147,732,000 | $277,961,000 |
| Cash Flow From Continuing Operating Activities | $287,195,000 | $224,164,000 | $-147,732,000 | $277,961,000 |
| Operating Gains Losses | $8,654,000 | $-16,124,000 | $4,420,000 | $-1,007,000 |
| Investing Activities | ||||
| Capital Expenditure | $-138,018,000 | $-179,070,000 | $-214,975,000 | $-182,378,000 |
| Investing Cash Flow | $-135,144,000 | $-178,996,000 | $-214,906,000 | $-181,896,000 |
| Cash Flow From Continuing Investing Activities | $-135,144,000 | $-178,996,000 | $-214,906,000 | $-181,896,000 |
| Net Other Investing Changes | $2,874,000 | $74,000 | $69,000 | $32,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-100,534,000 | $-50,564,000 | $265,959,000 | $197,761,000 |
| Cash Flow From Continuing Financing Activities | $-100,534,000 | $-50,564,000 | $265,959,000 | $197,761,000 |
| Net Other Financing Charges | $-7,862,000 | $-34,377,000 | $-27,452,000 | $-1,846,000 |
| Repurchase Of Capital Stock | - | $-4,428,000 | $-4,089,000 | $0 |
| Net Common Stock Issuance | - | $-4,428,000 | $-4,089,000 | $0 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Cash Dividends Paid | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-86,104,000 | $-2,271,109,000 | $-202,500,000 | $0 |
| Issuance Of Debt | $0 | $2,259,350,000 | $500,000,000 | $200,000,000 |
| Interest Paid Supplemental Data | $164,015,000 | $179,924,000 | $173,842,000 | $75,849,000 |
| Income Tax Paid Supplemental Data | $60,873,000 | $65,829,000 | $50,210,000 | $75,496,000 |
| End Cash Position | $346,456,000 | $278,865,000 | $301,654,000 | $396,294,000 |
| Beginning Cash Position | $278,865,000 | $301,654,000 | $396,294,000 | $106,924,000 |
| Effect Of Exchange Rate Changes | $16,074,000 | $-17,393,000 | $2,039,000 | $-4,456,000 |
| Changes In Cash | $51,517,000 | $-5,396,000 | $-96,679,000 | $293,826,000 |
| Proceeds From Stock Option Exercised | $-6,568,000 | $-4,428,000 | $-4,089,000 | $-393,000 |
| Net Issuance Payments Of Debt | $-86,104,000 | $-11,759,000 | $297,500,000 | $200,000,000 |
| Net Short Term Debt Issuance | $-86,104,000 | $-2,264,373,000 | $-202,500,000 | $0 |
| Short Term Debt Payments | $-86,104,000 | $-2,264,373,000 | $-202,500,000 | $0 |
| Net Long Term Debt Issuance | $0 | $2,252,614,000 | $500,000,000 | $200,000,000 |
| Long Term Debt Payments | $0 | $-6,736,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $2,259,350,000 | $500,000,000 | $200,000,000 |
| Net PPE Purchase And Sale | $-138,018,000 | $-179,070,000 | $-214,975,000 | $-182,378,000 |
| Purchase Of PPE | $-138,018,000 | $-179,070,000 | $-214,975,000 | $-182,378,000 |
| Change In Working Capital | $28,044,000 | $-42,634,000 | $-403,285,000 | $409,234,000 |
| Change In Other Working Capital | $28,539,000 | $-33,530,000 | $-371,788,000 | $395,668,000 |
| Change In Other Current Liabilities | $295,000 | $-3,793,000 | $-1,733,000 | $383,000 |
| Change In Other Current Assets | $-12,690,000 | $-3,244,000 | $3,765,000 | $-10,405,000 |
| Change In Payables And Accrued Expense | $7,126,000 | $470,000 | $-1,833,000 | $21,702,000 |
| Change In Accrued Expense | $1,941,000 | $7,114,000 | $3,500,000 | $20,595,000 |
| Change In Payable | $5,185,000 | $-6,644,000 | $-5,333,000 | $1,107,000 |
| Change In Account Payable | $5,185,000 | $-6,644,000 | $-5,333,000 | $1,107,000 |
| Change In Inventory | $-2,377,000 | $-4,753,000 | $-9,972,000 | $14,441,000 |
| Change In Receivables | $7,151,000 | $2,216,000 | $-21,724,000 | $-12,555,000 |
| Changes In Account Receivables | $7,151,000 | $2,216,000 | $-21,724,000 | $-12,555,000 |
| Other Non Cash Items | $4,942,000 | $28,677,000 | $6,145,000 | $886,000 |
| Stock Based Compensation | $30,878,000 | $36,777,000 | $32,238,000 | $21,211,000 |
| Deferred Tax | $22,000 | $9,433,000 | $3,449,000 | $-73,960,000 |
| Deferred Income Tax | $22,000 | $9,433,000 | $3,449,000 | $-73,960,000 |
| Depreciation Amortization Depletion | $136,706,000 | $163,637,000 | $157,925,000 | $145,554,000 |
| Depreciation And Amortization | $136,706,000 | $163,637,000 | $157,925,000 | $145,554,000 |
| Amortization Cash Flow | $41,798,000 | $79,377,000 | $81,348,000 | $81,554,000 |
| Amortization Of Intangibles | $41,798,000 | $79,377,000 | $81,348,000 | $81,554,000 |
| Depreciation | $94,908,000 | $84,260,000 | $76,577,000 | $64,000,000 |
| Gain Loss On Investment Securities | $-863,000 | $2,213,000 | $-1,637,000 | $2,977,000 |
| Net Foreign Currency Exchange Gain Loss | $9,517,000 | $-18,337,000 | $6,057,000 | $-3,984,000 |
| Net Income From Continuing Operations | $77,949,000 | $44,398,000 | $51,376,000 | $-233,570,000 |
| Common Stock Payments | - | $-4,428,000 | $-4,089,000 | $0 |
| Net Business Purchase And Sale | - | $0 | $0 | $450,000 |
| Sale Of Business | - | $0 | $0 | $450,000 |
| Asset Impairment Charge | - | $0 | $0 | $9,613,000 |
| Purchase Of Business | - | - | $0 | $0 |
| Short Term Debt Issuance | - | - | - | $200,000,000 |
Fetched: 2026-06-15